Related Experiment Video
Updated: Apr 18, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
13.5K
Guidelines for translational research in heart failure.
Enrique Lara-Pezzi1, Philippe Menasché, Jean-Hugues Trouvin
1Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain, elara@cnic.es.
Journal of Cardiovascular Translational Research
|January 22, 2015
Summary
Developing new heart failure (HF) therapies requires better preclinical studies. These guidelines offer recommendations to improve animal models, enhancing clinical trial success and new HF treatment development.
Area of Science:
- Cardiology
- Translational Medicine
- Preclinical Research
Background:
- Heart failure (HF) is a leading cause of death and hospitalization globally.
- Current HF treatments have limitations, and patient prognosis remains poor.
- Developing novel HF therapies is crucial, necessitating improved preclinical research.
Purpose of the Study:
- To provide guidelines for enhancing the translational validity of preclinical heart failure (HF) studies.
- To improve the similarity between HF animal models and the human condition.
- To increase the success rate of novel therapeutic products in clinical trials.
Main Methods:
- Recommendations for optimizing preclinical study design in heart failure (HF) research.
- Strategies to improve the safety and efficacy assessment of new therapeutic products.
- Emphasis on adhering to good practice rules throughout the research and development process.
Main Results:
- Proposed guidelines aim to reduce the failure rate of HF therapies in clinical trials.
- Enhanced preclinical models are expected to improve the translation of research findings from animals to humans.
- Adherence to guidelines is anticipated to increase the likelihood of regulatory approval for new HF treatments.
Conclusions:
- Improved preclinical studies are essential for advancing heart failure (HF) therapy development.
- These guidelines offer a framework to enhance the predictive value of animal models for human HF.
- Implementing these recommendations can accelerate the delivery of effective new treatments to patients.
Related Concept Videos
01:30Heart Failure V: Medical Management
592
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
592
01:30Heart Failure IV: Classification and Diagnostic Evaluation
631
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
631
01:22Heart Failure VI: Adjunct Therapies
614
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
01:29Heart Failure II: Pathophysiology
1.6K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
01:30Heart Failure VII: Nursing Interventions
765
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
765
01:27Heart Failure I: Introduction
1.4K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K